Causes and Effects of Oocyte Retrieval Difficulties: A Retrospective Study of 10,624 Cycles

Yang Wang, Meixiang Zhang, Hao Shi, Shiqi Yi, Qian Li, Yingchun Su, Yihong Guo, Linli Hu, Jing Sun, Yingpu SunFrontiers in Endocrinology 2022 · DOI

TL;DR

This study investigated the causes and consequences of "oocyte retrieval difficulties" (ORNS), defined as obtaining fewer oocytes than the number of mature follicles. They found that ORNS is linked to factors like older age, longer infertility duration, and endometriosis, and surprisingly, it doesn't impact fresh embryo transfer success but significantly reduces cumulative pregnancy and live birth rates.

What Problem Does This Paper Address?

In assisted reproductive technology (ART), oocyte retrieval is a crucial step to collect eggs for fertilization. While generally routine, sometimes clinicians encounter difficulties in obtaining a satisfactory number of oocytes, even when mature follicles are present. This phenomenon, termed "oocyte retrieval not satisfactory" (ORNS), has been poorly understood, with limited research on its underlying causes and its impact on treatment outcomes. This paper aims to shed light on these aspects by analyzing a large cohort of IVF/ICSI cycles.

Methods

The researchers conducted a retrospective study analyzing data from 10,624 oocyte retrieval cycles performed between April 2015 and June 2018. Patients were categorized into two groups: the "oocyte retrieval satisfactory" (ORS) group, where the number of retrieved oocytes met or exceeded the number of follicles >14mm on hCG day, and the "oocyte retrieval not satisfactory" (ORNS) group, where fewer oocytes were retrieved. They collected extensive data on patient demographics, infertility factors, ovarian stimulation protocols, hormone levels, and ART outcomes. Statistical analyses, including t-tests and chi-squared tests, were used to compare the two groups.

Datasets

The study utilized a dataset of 10,624 oocyte retrieval cycles from patients undergoing IVF or ICSI at the First Affiliated Hospital of Zhengzhou University. This dataset included detailed clinical information, stimulation parameters, and ART outcomes for each cycle. No new benchmarks were introduced; the study focused on analyzing existing clinical data.

Key Insights and Ideas

  • Endometriosis as a Key Culprit: The study reinforces endometriosis as a significant factor contributing to oocyte retrieval difficulties, potentially due to impaired cumulus expansion.
  • Ovarian Dysfunction is Central: Patients experiencing ORNS were more likely to have signs of ovarian dysfunction, suggesting that the underlying physiological state of the ovary plays a major role.
  • Stimulation Protocol Matters: The choice of ovarian stimulation protocol is crucial. The follicular phase long-acting GnRH agonist protocol was associated with lower oocyte retrieval difficulty, while the luteal phase short-acting GnRH agonist protocol was linked to higher difficulty.
  • Hormonal Imbalances on hCG Day: On the day of hCG administration, ORNS patients exhibited higher luteinizing hormone (LH) and lower estradiol and progesterone levels, hinting at a different follicular environment.
  • Counterintuitive Oocyte Quality: Despite fewer oocytes retrieved in the ORNS group, the quality of these oocytes and the fresh cycle transplantation rate were surprisingly higher.
  • Cumulative vs. Fresh Outcomes: The most striking finding is that while ORNS doesn't negatively impact the success of the fresh embryo transfer, it significantly diminishes the cumulative pregnancy and live birth rates. This suggests a long-term disadvantage for these patients.

Key Results

  • Prevalence: ORNS occurred in 12.18% of the studied cycles (1,294 out of 10,624).
  • Patient Characteristics: ORNS patients were older (32.78 vs. 31.22 years), had longer infertility durations (4.37 vs. 3.86 years), higher baseline FSH (7.55 vs. 6.77 mIU/ml), and a higher incidence of endometriosis (5.26% vs. 3.59%).
  • Stimulation Protocols: The follicular phase long-acting GnRH agonist protocol was used less in ORNS (64.61% vs. 79.89%), while the luteal phase short-acting GnRH agonist protocol was used more (28.59% vs. 15.62%).
  • Hormone Levels: On hCG day, ORNS patients had higher LH (1.29 vs. 1.16 U/L), lower estradiol (3144.43 vs. 3642.19 pg/ml), and lower progesterone (0.84 vs. 0.98 ng/ml).
  • Oocyte Retrieval: ORNS patients required significantly more follicular flushing (2.39 vs. 0.88 times) and retrieved fewer oocytes (6.93 vs. 14.57).
  • Embryo Quality: The MII rate (85.00% vs. 81.00%), fertilization rate (72.88% vs. 67.73%), and high-quality embryo rate (68.78% vs. 56.05%) were significantly higher in the ORNS group.
  • Fresh Cycle Outcomes: Biochemical pregnancy rate, clinical pregnancy rate, and live birth rate for fresh cycles were similar between groups.
  • Cumulative Outcomes: Cumulative pregnancy rate (57.26% vs. 73.56%) and cumulative live birth rate (49.61% vs. 65.48%) were significantly lower in the ORNS group.

Limitations and Future Work

The authors acknowledge that the study is retrospective, which inherently has limitations in establishing causality. They also note that while they identified associations, the precise mechanisms behind some findings, like the higher oocyte quality in ORNS despite fewer oocytes, require further investigation. Future research could focus on prospective studies to confirm these findings and explore interventions to mitigate the negative impact of ORNS on cumulative ART success. The study also highlights the need for further investigation into the value of follicular flushing, as it was used in over half of the cycles in their clinic.

Summary updated

Abstract

Oocyte retrieval is a routine procedure during the application of assisted reproduction technology. However, technical difficulties experienced during oocyte retrieval and the subsequent unsatisfactory number of oocytes obtained are rarely reported. The current study included 10,624 oocyte retrieval cycles from April 2015 to June 2018, and patients were followed up until February 2019. Patients were divided into two groups depending on whether the oocyte number obtained reached the >14-mm follicle number on the day of hCG administration. In the oocyte retrieval not satisfactory (ORNS) group, there were 1,294 cycles, and in the oocyte retrieval satisfactory (ORS) group, there were 9,330 cycles. ORNS patients were older, had a longer duration of infertility, had higher follicle-stimulating hormone, and were more likely to have endometriosis. The ORS group had a higher rate of the use of a follicular phase long-acting gonadotropin-releasing hormone (GnRH) agonist long ovarian stimulation protocol and a lower rate of the use of a luteal phase short-acting GnRH agonist long protocol. The ORNS group had fewer total number of days of FSH stimulation. On human chorionic gonadotropin day, the ORNS group had higher luteinizing hormone (LH), lower estradiol, and lower progesterone levels. After oocyte retrieval, the oocyte quality and fresh cycle transplantation rate were higher in the ORNS group. An unsatisfactory oocyte retrieval number did not influence the clinical pregnancy rate, miscarriage rate, or live birth rate during the fresh cycles. The cumulative pregnancy rate and the live birth rate were lower in the ORNS group. In conclusion, with a similar number of matured follicles, ORNS was more likely to occur in ovarian dysfunction patients. The follicular phase long-acting GnRH agonist long protocol had lower oocyte retrieval difficulty during IVF/ICSI. ORNS does not affect embryo quality or the fresh cycle pregnancy rate, but it significantly reduces the cumulative pregnancy rate and the live birth rate.
BibTeX
@inproceedings{wang2022causes,
  author = {Yang Wang and Meixiang Zhang and Hao Shi and Shiqi Yi and Qian Li and Yingchun Su and Yihong Guo and Linli Hu and Jing Sun and Yingpu Sun},
  title = {{Causes and Effects of Oocyte Retrieval Difficulties: A Retrospective Study of 10,624 Cycles}},
  booktitle = {Frontiers in Endocrinology},
  year = {2022},
  doi = {10.3389/fendo.2021.564344},
}
Figure